The Advisory Council’s Critical Roles

5 comments

Later this month, the National Advisory General Medical Sciences Council will hold the first of its three meetings in 2011. While many applicants, grantees and reviewers are familiar with the roles and processes of study sections, fewer know how an advisory council works. In this post, I’ll provide an overview of its many critical roles.

Council members are leaders in the biological and medical sciences, education, health care and public affairs. Their areas of expertise cover the broad range of scientific fields supported by NIGMS. The Council performs the second level of peer review for research and research training grant applications assigned to NIGMS. Council members also offer advice and recommendations on policy and program development, program implementation, evaluation and other matters of significance to the mission and goals of the Institute.

A portion of each Council meeting is open to the public.

For the peer review function, which occurs during the part of the meeting that is closed to the public, Council members read summary statements, providing a general check on the quality of the first level of peer review. They advise us if they find cases where the comments and scores do not appear to be in good alignment. Their evaluation complements the initial peer review done by study sections, as it focuses primarily on summary statements rather than on applications (although Council members may have access to the applications).

Members also provide advice regarding formal appeals, typically discussing 10-20 cases per meeting in which a procedural aspect may have significantly influenced the initial peer review process.

The Council also provides input on cases where staff are considering exceptions to the well-funded laboratory policy, and it approves the potential funding of grants to investigators at foreign institutions. Another area of Council input relates to Method to Extend Research in Time (MERIT) awards. Finally, Council members point out applications that they feel are particularly interesting based on their scientific expertise and knowledge of trends in particular fields. They explain their perspective to NIGMS staff, who incorporate this input in subsequent steps of the funding decision process. I’ll describe these steps in an upcoming post.

The policy and program advisory function includes discussing “concept clearances,” or ideas for new initiatives being considered within the Institute. These can take the form of proposed requests for applications (RFAs) or program announcements (PAs). Council members provide critical analysis and feedback about the appropriateness of proposed initiatives and factors to consider should they be implemented. Approved concept clearances are posted soon after each Council meeting on the NIGMS Web site and often on the Feedback Loop. NIGMS staff can then receive input from the scientific community as they refine the funding opportunity announcements.

This month’s meeting will include one concept clearance presentation, on macromolecular complexes.

Council members also give input and feedback on assessments and formal evaluations of specific NIGMS programs, such as the Protein Structure Initiative. When the need arises, Council members form working groups focused on specific issues. To ensure an appropriate range of expertise and perspectives, these groups can include non-Council members, as well. Finally, the Council receives periodic reports about ongoing initiatives in order to monitor how they are proceeding and offer advice about possible changes.

PSI Tools for Your Lab

0 comments

Short articles summarizing PSI tools and technologiesOver the course of its 10-year existence, the Protein Structure Initiative has supported the development of new technologies and methods that improve the throughput of protein structure determination. Many of them apply to the production of purified proteins for functional and structural studies, and you don’t need access to major research centers to use them.

To help you take advantage of these resources, the PSI Structural Biology Knowledgebase Link to external web site offers a series of short articles summarizing tools and technologies developed by PSI-supported investigators. You may also request plasmid clones via the PSI Materials Repository Link to external web site.

As always, you can nominate targets for PSI investigators to solve.

If you’re going to the 2011 American Crystallographic Association meeting (May 28-June 2 in New Orleans) and want to know more about using these PSI products in your own lab, plan on attending my session, “PSI Tools for the Home Lab.” Also, the Structural Biology Knowledgebase will offer workshops at the International Conference of Structural Genomics (May 10-14 in Toronto).

Fiscal Year 2010 R01 Funding Outcomes and Estimates for Fiscal Year 2011

17 comments

Fiscal Year 2010 ended on September 30, 2010. We have now analyzed the overall results for R01 grants, shown in Figures 1-3.

Figure 1. Competing R01 applications reviewed (open rectangles) and funded (solid bars) in Fiscal Year 2010.

Figure 1. Competing R01 applications reviewed (open rectangles) and funded (solid bars) in Fiscal Year 2010.
Figure 2. NIGMS competing R01 funding curves for Fiscal Years 2006-2010. The thicker curve (black) corresponds to grants made in Fiscal Year 2010. The success rate for R01 applications was 27%, and the midpoint of the funding curve was at approximately the 21st percentile. These parameters are comparable to those for Fiscal Year 2009, excluding awards made with funds from the American Recovery and Reinvestment Act.

Figure 2. NIGMS competing R01 funding curves for Fiscal Years 2006-2010. The thicker curve (black) corresponds to grants made in Fiscal Year 2010. The success rate for R01 applications was 27%, and the midpoint of the funding curve was at approximately the 21st percentile. These parameters are comparable to those for Fiscal Year 2009, excluding awards made with funds from the American Recovery and Reinvestment Act.

The total NIGMS expenditures (including both direct and indirect costs) for R01 grants are shown in Figure 3 for Fiscal Year 1996 through Fiscal Year 2010.

Figure 3. Overall NIGMS expenditures on R01 grants (competing and noncompeting, including supplements) in Fiscal Years 1995-2010. The dotted line shows the impact of awards (including supplements) made with Recovery Act funds. Results are in actual dollars with no correction for inflation.

Figure 3. Overall NIGMS expenditures on R01 grants (competing and noncompeting, including supplements) in Fiscal Years 1995-2010. The dotted line shows the impact of awards (including supplements) made with Recovery Act funds. Results are in actual dollars with no correction for inflation.

What do we anticipate for the current fiscal year (Fiscal Year 2011)? At this point, no appropriation bill has passed and we are operating under a continuing resolution through March 4, 2011, that funds NIH at Fiscal Year 2010 levels. Because we do not know the final appropriation level, we are not able at this time to estimate reliably the number of competing grants that we will be able to support. We can, however, estimate the number of research project grant applications in the success rate base (correcting for applications that are reviewed twice in the same fiscal year). We predict that this number will be approximately 3,875, an increase of 17% over Fiscal Year 2010.

UPDATE: The original post accidentally included a histogram from a previous year. The post now includes the correct Fiscal Year 2010 figure.

Register for 25th Annual NIGMS AIDS-Related Structural Biology Meeting

0 comments

X-ray structure of hexameric HIV-1 CA (PDB entry 3H47)

Registration is now open for the 25th Annual Meeting of the Groups Studying the Structures of AIDS-Related Systems and Their Application to Targeted Drug Design. The meeting will take place March 28-30, 2011, on the NIH campus in Bethesda.

Plenary sessions will cover the HIV life cycle, host-pathogen interactions, imaging, latency, viral host recognition and structure-based drug design and resistance. The first two days will also include afternoon poster sessions and breakout discussion groups on the future of NIGMS AIDS research initiatives.

Principal investigators, postdoctoral fellows and students are welcome to attend. The meeting is free and open to the public, but advance registration is required. If you’d like to submit a poster presentation, please check the speaker box on the meeting registration page and e-mail me.

The focus of NIGMS-supported HIV studies has evolved from determining the structures of AIDS-related proteins and developing structure-based drug design techniques to identifying mechanisms of drug resistance and host proteins related to the HIV life cycle.

During this special anniversary meeting, the community will have an opportunity to reflect on past accomplishments, describe current advances and develop ideas for future NIGMS AIDS-related funding opportunities. Please visit the meeting Web site for more details about the agenda and confirmed speakers.

We hope to see you in March!

Cell Biology Celebration

1 comment

The American Society for Cell Biology 50th Annual MeetingCell biologists, including many of our funded investigators and a few of us from NIGMS, were in a celebratory mood as the 50th Annual Meeting of the American Society for Cell Biology Link to external web site kicked off December 11 at the Philadelphia Convention Center. The keynote symposium began with Gary Borisy’s description of the first ASCB meeting, when Hans Ris described his then-heretical finding that chloroplasts contain DNA. For more details about the genesis and early years of the ASCB, check out John Fleishman’s article, A Place of Our Own, in the December 2010 ASCB Newsletter.

An exciting addition to this year’s meeting was the science discussion table format. Eminent researchers sat at tables for an hour at the beginning of each poster session and took questions from relative newcomers to the field. I stopped by to say hello to some of the NIGMS-supported investigators in my grant portfolio, but each table was crowded with graduate students and postdocs eager to discuss science and seek advice from their fields’ leaders. Two thoughts came to mind as I watched the scene unfold: I wish that there had been these tables when I was a young scientist, and I hope this format becomes a regular feature of the ASCB meeting.

While science is the major focus of the ASCB meeting, education, mentoring and career development also are important features. A number of education workshops focused on topics such as pedagogy, science literacy and online teaching resources. Women in Cell Biology-sponsored events focused on careers, mentoring and managing life as a scientist. In addition, NIH program and review staff answered questions about the grant process. I was one of them, and my favorite part was talking to postdocs and investigators I know from phone calls and e-mail exchanges.

I saw a number of outstanding talks and posters at the meeting, and to say that there is not enough room here to mention them all is an understatement. I was particularly intrigued by presentations from Ron Vale’s lab at University of California, San Francisco, on the cytoplasmic dynein motor domain at 6 Å resolution and from Tom Schwarz at Harvard Medical School on identifying a role for Parkinson’s disease-associated proteins in the regulation of mitochondrial transport within axons. As someone interested in intracellular transport, both presentations offered answers to long-standing problems in cell biology and provided a launching pad for testing new ideas about how organelles move to specific cellular destinations.

I’m already looking forward to the 2011 meeting in Denver.

Important Application Reminders for January Submissions

0 comments

NIH has issued a notice with important reminders affecting grant applications submitted on or after January 25.

The NIH policy on page limits means that reviewers need not consider text or materials that have been inappropriately placed in the Appendix or other sections without page limits, particularly when they circumvent page limitations for the Specific Aims and Research Strategy sections. In some instances, NIH may withdraw the application from review or funding consideration. For a reminder of what’s acceptable in the Appendix, see NOT-OD-10-077.

Also, post-submission application materials must adhere to new restrictions on timing and content; see NOT-OD-10-091.

As I previously posted on August 20 and October 8, other application policy changes also on the way for submissions on or after January 25 include:

  1. Elimination of the error correction window from the application process for electronic and paper-based submissions; see NOT-OD-10-123.
  2. Resubmission deadlines of no more than 37 months after the receipt date of the initial application; see NOT-OD-10-140.
  3. New application forms for F, K, T and D series applications, which will apply to all other applications as of May 7, 2011; see NOT-OD-11-007 and NOT-OD-11-008.

Stepping Down as NIGMS Director

18 comments

This morning, I announced that I will step down as NIGMS Director at the end of June 2011. I had no intention of leaving NIGMS at this point, but am doing so in support of the career of my wife, Wendie, a leading breast imaging clinical researcher. After a change in her situation in May, we have been looking for a suitable position for her to continue her work on testing new methods for breast cancer screening. She has been actively recruited by a number of institutions around the country, and we have particularly explored options in the Baltimore-Washington area.

After considering all known options, we have decided to accept positions at the University of Pittsburgh. She will be starting in the Department of Radiology at Magee-Womens Hospital of UPMC in March 2011. I will be waiting until the end of June to move in order to complete some important projects at NIGMS and to allow our youngest child to finish her freshman year of high school. I will be serving as the University of Pittsburgh’s Associate Senior Vice Chancellor for Science Strategy and Planning in the Health Sciences and as a faculty member in the School of Medicine’s Department of Computational and Systems Biology.

My time at NIGMS has been one of the highlights of my career. When I joined the Institute more than 7 years ago, I was immediately impressed with the dedication and competence of the staff at all levels. During my tenure, we have been able to recruit a number of outstanding individuals to join this team. So while I am very sad to leave such an outstanding organization, I am confident that it will be in good hands, and I look forward to the new adventures that await me and my family.

Another Look at Measuring the Scientific Output and Impact of NIGMS Grants

33 comments

In a recent post, I described initial steps toward analyzing the research output of NIGMS R01 and P01 grants. The post stimulated considerable discussion in the scientific community and, most recently, a Nature news article Link to external web site.

In my earlier post, I noted two major observations. First, the output (measured by the number of publications from 2007 through mid-2010 that could be linked to all NIH Fiscal Year 2006 grants from a given investigator) did not increase linearly with increased total annual direct cost support, but rather appeared to reach a plateau. Second, there were considerable ranges in output at all levels of funding.

These observations are even more apparent in the new plot below, which removes the binning in displaying the points corresponding to individual investigators.

A plot of the number of grant-linked publications from 2007 to mid-2010 for 2,938 investigators who held at least one NIGMS R01 or P01 grant in Fiscal Year 2006 as a function of the total annual direct cost for those grants. For this data set, the overall correlation coefficient between the number of publications and the total annual direct cost is 0.14.

A plot of the number of grant-linked publications from 2007 to mid-2010 for 2,938 investigators who held at least one NIGMS R01 or P01 grant in Fiscal Year 2006 as a function of the total annual direct cost for those grants. For this data set, the overall correlation coefficient between the number of publications and the total annual direct cost is 0.14.

The 10th Anniversary of ABRCMS: Preparing Underrepresented Minority Students for Scientific Careers

1 comment
The 10th Anniversary of ABRCMS: Preparing Underrepresented Minority Students for Scientific Careers

Last week, I had the privilege of giving a keynote address at the 10th Annual Biomedical Research Conference for Minority Students (ABRCMS) Link to external website in Charlotte, North Carolina. The conference, sponsored by NIGMS and organized by NIGMS Council member Cliff Houston, had a record attendance of 3,100, including more than 2,000 students and about 20 NIGMS staff members.

The meeting contributes in two major ways to the goal of a scientific workforce that reflects the diversity of the U.S. population. It provides a forum for promising scientists from underrepresented groups to showcase their talent and knowledge and make important training and career connections. It also gives faculty mentors valuable resources for facilitating their students’ success.

My address was organized around the themes from Randy Pausch’s lecture “Really Achieving Your Childhood Dreams Link to external website,” and it described key events and strategies that facilitated my own path to a career in science. I greatly enjoyed discussing science and career opportunities with many of the students at the poster session and after my talk.

Other keynote speakers at this impressive conference included Neil DeGrasse Tyson, Maya Angelou, NIH Director Francis Collins and NIGMS grantee Carolyn Bertozzi.

Jilliene Mitchell, who staffed the NIGMS exhibit booth and talked to a lot of attendees, writes:

The energy level among the meeting attendees soared through the roof of the Charlotte Convention Center. The undergraduate and graduate students were tremendously enthusiastic about networking, presenting their research, listening to scientific talks and getting advice about their career paths from accomplished scientists. The NIGMS exhibit booth received a lot of traffic, with students lined up to talk about training opportunities and faculty members lined up to discuss their grants.

Throughout the conference, I encountered many students who thanked NIGMS for sponsoring ABRCMS. One postdoc summed it up best when she said, “This is the best career development workshop I’ve been to—it’s huge!”

These video clips I took capture the mood and excitement.

The announcement for next year’s ABRCMS meeting is expected soon, and we will post information here when it is available.

Assessing the Outcomes of NIGMS Glue Grants

11 comments

NIGMS Glue Grants Outcomes Assessment, November 4-December 15In September 2009, we announced that we were not reissuing the funding opportunity announcement for our Large-Scale Collaborative Project Awards (Glue Grant) program, which has supported research teams tackling significant and complex problems that are beyond the means of any one research group. We are currently assessing the need for this type of support and how best to manage programs of such scope and magnitude.

As part of this effort, we are conducting an assessment of the glue grant program’s major outcomes and their impact. We’re seeking your views through voluntary input forms posted on the NIGMS Web site. The forms will ask about various aspects of the glue grant program as a whole and about specific glue grant projects, including:

You can read more about the assessment and view the forms at http://www.nigms.nih.gov/Initiatives/Collaborative/GlueGrants/OutcomeAssessment. The site will be open for input until December 15, 2010.

UPDATE: We have extended the comment period from December 15 to January 15.